T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients
T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients
Recruiting · NCT05141058 · Registry updated 2026-03-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 1 | 2026-03-12 | NCT05141058 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Children's National Research Institute | 84 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's National Hospital | Washington D.C. | United States | 100 |
| The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University | Baltimore | United States | 1 |